EFH Ltd 8YY

SGD 0.022 +0.00% +0.00 Updated 16 Nov 2026, 17:16 SGT

Company profile

The business, the people and the ownership behind EFH Ltd.

Business overview

About the company

Embracing Future Holdings operates a portfolio with cancer and infectious disease-related business segments, together with e-sports and advertising activities.

Annual Report 2025 ↗ Reviewed 2026-10-23 · Source dated 2026-04-13. PDF p. 140

Listed security

Company & listing

Full Company Name
EMBRACING FUTURE HOLDINGS LIMITED
Trading Currency
SGD
Website
www.ebfholdings.com
Listing
Listed on 19 December 2018 on CATALIST
ISIN Code
SGXE89830751

Board & management

Leadership

Five directors, including Chairman and Interim CEO Zhu Hua and President Chen Lu. Financial Controller Lau Wei Kian and secretary Nor Hafiza Alwi separately named. CEO title is confirmed in governance page42, despite the shorter Board biography title; outside CEO/CFO roles are not attributed to issuer.

Annual-report leadership comprises five directors, including Executive Chairman and Interim CEO Zhu Hua from 30 June 2024, and President Chen Lu. Lau Wei Kian is Financial Controller, not relabelled CFO; Nor Hafiza Alwi is Company Secretary. External CEO/CFO titles in Joseph Liew and Ian Brown biographies are not issuer offices. Company renamed from Biolidics per 24 June 2025 legal notice; trading counter changed 27 June 2025. Frozen SGX IBM code 1EI2 is not current ISIN prefix; official announcement and corporate information independently confirm SGXE89830751.

Zhu Hua

Executive Director, Chairman and Interim CEO

Interim CEO assumed30June2024 after previous CEO resigned; annual corporate-governance page42 states he continues until a suitable replacement is found. Not a permanent CEO appointment.

Chen Lu

Executive Director and President

President since30April2024; distinct from Interim CEO Zhu Hua.

Liew Yoke Pheng Joseph

Independent Director

Audit and Risk Committee Chairman. Prior Hoe Leong CEO and outside CFO roles are not issuer executive offices.

Ch’ng Li-Ling

Lead Independent Director

Redesignated Lead Independent Director18June2024; Nominating Committee Chairman.

Ian David Brown

Independent Director

Remuneration Committee Chairman. Yallingup Ventures CEO and other outside roles are not issuer CEO.

Lau Wei Kian

Financial Controller

Named Group Financial Controller responsible for reporting, internal control and HR. Not relabelled Chief Financial Officer.

Nor Hafiza Alwi

Company Secretary

Annual-report Company Secretary.

Roles listed in Annual Report 2025; current appointments are not independently verified.

Holdings

Ownership

Twenty registered accounts, one major-holder row and nine context disclosures. Zhu505,500,000 is expressly deemed through OCBC, not a second direct block; original misaligned29.16% column is retained and qualified.

Source register capital63,803,342 differs from financial statement capital74,653 thousand despite the same issued-share count. Both figures and dates retained; no unsupported reconciliation supplied.

Register 20 March 2026:1,733,441,815 ordinary shares, no treasury or subsidiary holdings,1,947 holders and top 20 total 1,552,538,921 shares 89.56%; public float 62.79%. Zhu Hua narrative states deemed 505,500,000 through OCBC. Original table prints 29.16% in direct-percentage column while direct share number is dash and deemed-percentage dash. Do not invent a separate direct block or silently move source cells. Register capital 63,803,342 differs from statement/Note 27 capital 74,653 thousand by 10,849,658 SGD, despite the same issued-share count; both amounts/dates retained, no bridge disclosed.

Zhu Hua

Deemed interest505,500,000 shares held through OCBC Securities Private Ltd; original table prints direct number–,29.16% in direct-percentage column, deemed number505,500,000 and deemed-percentage–

Register20March2026. Narrative expressly identifies deemed holding. Printed29.16% is misplaced under direct percentage; do not turn it into a separate direct share block or silently rewrite original columns. OCBC registered946,566,100 includes other holdings; not all belongs to Zhu. As reported at 2026-03-20

Issued ordinary shares

1,733,441,815 shares

One vote per ordinary share; register20March2026. As reported at 2026-03-20

Treasury shares

Nil

Explicit no treasury shares. As reported at 2026-03-20

Subsidiary holdings

Nil

Explicit no subsidiary holdings. As reported at 2026-03-20

Distribution total shareholders

1,947 holders

Registered distribution total. As reported at 2026-03-20

Twenty largest registered holders

1,552,538,921 shares;89.56%

Registered concentration, distinct from public float. As reported at 2026-03-20

Public float

62.79%

Rule723 public holdings. As reported at 2026-03-20

Register issued and paid-up share capital

$63,803,342

Register20March2026 prints this SGD capital figure. Financial statement and Note27 report SGD74,653 thousand for31December2025, with the same1,733,441,815 share count; original capital difference retained, no invented reconciliation. As reported at 2026-03-20

Financial-statement issued share capital

SGD74,653 thousand;1,733,441,815 shares

31December2025 Note27 whole-share versus SGD-thousand columns. Register capital63,803,342 has separate date and inconsistent amount. As reported at 2025-12-31

Deemed and registered overlap

505,500,000 of OCBC registered946,566,100 shares

Original narrative identifies Zhu deemed block. Do not sum it again with the nominee register balance. As reported at 2026-03-20

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-03-20 · PDF p. 145

Registered holderInterestShares / unitsSource
OCBC SECURITIES PRIVATE LTD946,566,100 shares; 54.61%PDF p. 1452026-03-20
ZHOU CHAO83,000,000 shares; 4.79%PDF p. 1452026-03-20
CHEN LU76,000,000 shares; 4.38%PDF p. 1452026-03-20
WU KUN WEI72,003,600 shares; 4.15%PDF p. 1452026-03-20
PHILLIP SECURITIES PTE LTD70,014,645 shares; 4.04%PDF p. 1452026-03-20
YUAN ZHI JUN63,596,400 shares; 3.67%PDF p. 1452026-03-20
CGS INTERNATIONAL SECURITIES SINGAPORE PTE LTD40,268,600 shares; 2.32%PDF p. 1452026-03-20
TOMORROW HOLDING LIMITED35,000,000 shares; 2.02%PDF p. 1452026-03-20
MOOMOO FINANCIAL SINGAPORE PTE. LTD.28,639,700 shares; 1.65%PDF p. 1452026-03-20
DBS NOMINEES PTE LTD20,713,636 shares; 1.19%PDF p. 1452026-03-20
IFAST FINANCIAL PTE LTD20,587,530 shares; 1.19%PDF p. 1452026-03-20
TRAUWIN PTE. LIMITED19,044,600 shares; 1.10%PDF p. 1452026-03-20
KGI SECURITIES (SINGAPORE) PTE. LTD12,846,873 shares; 0.74%PDF p. 1452026-03-20
TIGER BROKERS (SINGAPORE) PTE. LTD.12,398,500 shares; 0.72%PDF p. 1452026-03-20
UOB KAY HIAN PTE LTD10,614,300 shares; 0.61%PDF p. 1452026-03-20
SOH CHUN BIN (SU CHUNBIN)9,999,937 shares; 0.58%PDF p. 1452026-03-20
RAFFLES NOMINEES (PTE) LIMITED9,685,700 shares; 0.56%PDF p. 1452026-03-20
ABN AMRO CLEARING BANK N.V.9,128,900 shares; 0.53%PDF p. 1452026-03-20
LIM CHWEE TECK7,330,600 shares; 0.42%PDF p. 1452026-03-20
HSBC (SINGAPORE) NOMINEES PTE LTD5,099,300 shares; 0.29%PDF p. 1452026-03-20

Group structure

Main operating subsidiaries and other group entities

Eight original schedule rows: six current subsidiaries and two former entities with dashes, not eight current operating businesses. Dormant Biolidics Pty and MCN entities remain named. No separate associate/JV schedule is disclosed in this source.

MCN Technology Pte ownership diluted100% to51% on9July2025; HK entity incorporated31December2025 is held through it. Note15 prints HK100% under effective Company heading; original wording and intermediate route are both preserved without replacing them with an inferred percentage. E-Sports HK incorporated25August2025; Shenzhen acquired22October2024 through E-Sports Singapore.

Note 15 has six current subsidiary rows plus two former rows, including dormant entities and exact intermediate holding routes. Biomedics Laboratory entered voluntary liquidation 4 July 2024 and Shanghai deregistered 8 October 2024 have no current holding. MCN Technology Singapore diluted 100% to 51% on 9 July 2025; its HK subsidiary prints 100% under an effective Company heading despite that intermediate parent. Both original heading and route are retained without falsely claiming 100% ultimate ownership. E-Sports HK incorporated 25 August 2025 and MCN HK 31 December 2025. No separate associate/JV schedule is disclosed.

CompanyMarketOwnership interest
Biolidics Pty LtdHeld by Company. Dormant/active status and intermediate holding path remain as disclosed. Australia; printed equity2025/2024 100/100%; Dormant
Embracing Future E-Sports Pte. Ltd.Held by Company. Dormant/active status and intermediate holding path remain as disclosed. Singapore; printed equity2025/2024 100/100%; Integrated marketing services in the gaming industry (E-Sports)
Embracing Future MCN Technology Pte. Ltd.Held by Company. Dormant/active status and intermediate holding path remain as disclosed. Singapore; printed equity2025/2024 51/100%; Dormant
Shenzhen Xiaozhao Network Technology Co., Ltd (深圳市小钊网络科技有限责任公司)Held by Embracing Future E-Sports Pte. Ltd.. Dormant/active status and intermediate holding path remain as disclosed. People’s Republic of China; printed equity2025/2024 100/100%; Integrated marketing services in the gaming industry (E-Sports)
Embracing Future E-Sports (HK) LimitedHeld by Embracing Future E-Sports Pte. Ltd.. Dormant/active status and intermediate holding path remain as disclosed. Hong Kong; printed equity2025/2024 100/–; Integrated marketing services in the gaming industry (E-Sports)
Embracing Future MCN Technology (HK) LimitedHeld by Embracing Future MCN Technology Pte. Ltd.. Original schedule heading says effective Company equity. MCN Technology HK prints100% under a51%-held intermediate parent; retain printed basis and path without silently claiming100% ultimate effective ownership. Hong Kong; printed equity2025/2024 100/–; Dormant
Biomedics Laboratory Pte. Ltd.Held by Company. Former: liquidation4July2024 or deregistration8October2024 per original footnotes; no current holding printed. Singapore; printed equity2025/2024 –/–; Dormant
Biolidics (Shanghai) Co., Ltd. (明测生物医药(上海)有限公司)Held by Company. Former: liquidation4July2024 or deregistration8October2024 per original footnotes; no current holding printed. People’s Republic of China; printed equity2025/2024 –/–; Dormant

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
LAU WEI KIAN Financial Controller Group PDF p. 10
Nor Hafiza Alwi, FCIS COMPANY SECRETARY Company PDF p. 34

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
ISSUED AND PAID-UP SHARE CAPITAL $63,803,342 Company · As at 2026-03-20 PDF p. 145
NUMBER OF ISSUED SHARES 1,733,441,815 shares Company · As at 2026-03-20 PDF p. 145
CLASS OF SHARES ORDINARY SHARES Company · As at 2026-03-20 PDF p. 145
VOTING RIGHTS ON A POLL ONE VOTE PER SHARE Company · As at 2026-03-20 PDF p. 145

Treasury shares

ItemValuePeriod / scopeSource
NUMBER AND PERCENTAGE OF TREASURY SHARES Nil Company · As at 2026-03-20 PDF p. 145
NUMBER AND PERCENTAGE OF SUBSIDIARY HOLDINGS Nil Company · As at 2026-03-20 PDF p. 145

Shareholding distribution

ItemValuePeriod / scopeSource
TOTAL 1,947 shareholders Total shareholders; 100.00% of holders; 1,733,441,815 shares, 100.00% · As at 2026-03-20 PDF p. 145
1 - 99 22 holders; 1.13% of holders; 1,350 shares; 0.00% of shares Size band 1 - 99 · As at 2026-03-20 PDF p. 145
100 - 1,000 113 holders; 5.80% of holders; 70,196 shares; 0.00% of shares Size band 100 - 1,000 · As at 2026-03-20 PDF p. 145
1,001 - 10,000 579 holders; 29.74% of holders; 3,710,176 shares; 0.21% of shares Size band 1,001 - 10,000 · As at 2026-03-20 PDF p. 145
10,001 - 1,000,000 1,194 holders; 61.33% of holders; 134,759,172 shares; 7.78% of shares Size band 10,001 - 1,000,000 · As at 2026-03-20 PDF p. 145
1,000,001 & above 39 holders; 2.00% of holders; 1,594,900,921 shares; 92.01% of shares Size band 1,000,001 & above · As at 2026-03-20 PDF p. 145

Free float

ItemValuePeriod / scopeSource
PUBLIC SHAREHOLDINGS approximately 62.79% of the Company’s issued ordinary shares are held in the hands of the public Company · As at 2026-03-20 PDF p. 146
PUBLIC SHAREHOLDINGS the Company has complied with Rule 723 of the Listing Manual Section B: Rules of Catalist issued by SGX-ST. Company · As at 2026-03-20 PDF p. 146

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Mr Zhu Hua subscribed for 100,000 ordinary shares (at total subscription price of S$100,000) in the share capital of EFMCN Interested person transaction FY2025; Mr Zhu Hua with Embracing Future MCN Technology Pte. Ltd. (EFMCN) · As at 2025-07-09 PDF p. 63
Loan disbursement from 1,470 $'000 Group 2025; Director and Shareholder of the Company PDF p. 132
Loan repayment to (150) $'000 Group 2025; Director and Shareholder of the Company PDF p. 132

Director remuneration

ItemValuePeriod / scopeSource
Directors’ fees (Note 6) 120 $'000 Group and Company 2025 (2024: 149) PDF p. 132
Zhu Hua 240,000 S$ FY2025, total, S$ PDF p. 51
Chen Lu 204,000 S$ FY2025, total, S$ PDF p. 51
Ch’ng Li-Ling 40,000 S$ FY2025, total, S$ PDF p. 51
Ian David Brown 40,000 S$ FY2025, total, S$ PDF p. 51
Liew Yoke Pheng Joseph 40,000 S$ FY2025, total, S$ PDF p. 51

Employees

ItemValuePeriod / scopeSource
workforce totalled 16 employees Group, as at 31 December 2025 · As at 2025-12-31 PDF p. 25

Subsequent events

ItemValuePeriod / scopeSource
Events occurring after the reporting period Subsequent to the end of the financial year, the Company entered into a series of conditional acquisition and share issuance arrangements Group, announced 9 January 2026, updated 16 March 2026 PDF p. 143
Non-adjusting subsequent events The above events are non-adjusting subsequent events Group PDF p. 144

Outlook

ItemValuePeriod / scopeSource
Forging Ahead We are transitioning from a period of restructuring to one of execution and scaling. Chairman Zhu Hua, Message to Shareholders PDF p. 5

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

Source: Annual Report 2025 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
19 Jul 2009
Email
[email protected]
Telephone
65 64820668
Registered Office
122 Emerald Hill Road
Singapore 229405
Secretary
Nor Hafiza Alwi
Registrar / Transfer Agent
B.A.C.S. PRIVATE LIMITED
Registrar Address
77 Robinson Road, #06-03 Robinson 77, Singapore 068896
Auditors
PKF-CAP LLP
Other Stock Exchange Listings
*SINGAPORE EXCHANGE (CATALIST)
Country
SINGAPORE
Security Type
stocks